Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS
Home/The Filing Wire/Immuneering Corporation/ 3

Initial Beneficial Ownership · 3

Immuneering Corporation

IMRXNASDAQEQUITYCurrent

Initial Beneficial Ownership

Filed Jul 16, 2026Accepted Jul 16, 2026, 4:10 PM EDTFiling CIK 1790340Accession 0001790340-26-000080
View company →Permanent SEC source ↗
Share

Structured filing — 3

wk-form3_1784232635.xml

Open full document ↗

Filing details

Report period
2026-07-16
Issuer
Immuneering Corp
Issuer CIK
0001790340
Trading symbol
IMRX

Reporting owner 1

Name
Gengos Andrew
Reporting owner CIK
0001563623
Relationship
Officer
Officer title
Chief Financial Officer
Address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142

Non-derivative holdings

Non-derivative holdings · 1 reported row
SecurityAmount ownedOwnership
Class A Common Stock225,000D
Table key
D
Direct

Signature 1

Signed
/s/ Michael D. Bookman, Attorney-in-Fact for Andrew Gengos
Date
2026-07-16

Filed exhibits

Company context

Current securities

IMRXNASDAQ · EQUITY · Current

Recent company filings

  1. 10-Q filingOct 29, 2026
  2. Results of Operations and Financial ConditionOct 29, 2026
  3. 10-Q filingAug 5, 2026
  4. Results of Operations and Financial ConditionAug 5, 2026
  5. 4 filingJul 17, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.